177 related articles for article (PubMed ID: 29343809)
1. Interaction of smoking and metabolic syndrome in increasing the recurrence risk of colorectal cancer in a Chinese male cohort: a retrospective study.
Chen DZ; Ji FY; Xu QM; Wu XX; Cai C; Zhang LJ; Li LJ
Sci Rep; 2018 Jan; 8(1):972. PubMed ID: 29343809
[TBL] [Abstract][Full Text] [Related]
2. The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.
Chen ZF; Dong XL; Huang QK; Hong WD; Wu WZ; Wu JS; Pan S
World J Surg Oncol; 2018 Aug; 16(1):163. PubMed ID: 30097069
[TBL] [Abstract][Full Text] [Related]
3. The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.
Pan S; Hong W; Wu W; Chen Q; Zhao Q; Wu J; Jin Y
Medicine (Baltimore); 2017 Jan; 96(2):e5809. PubMed ID: 28079806
[TBL] [Abstract][Full Text] [Related]
4. Smoking and survival of colorectal cancer patients: population-based study from Germany.
Walter V; Jansen L; Hoffmeister M; Ulrich A; Chang-Claude J; Brenner H
Int J Cancer; 2015 Sep; 137(6):1433-45. PubMed ID: 25758762
[TBL] [Abstract][Full Text] [Related]
5. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer.
You J; Liu WY; Zhu GQ; Wang OC; Ma RM; Huang GQ; Shi KQ; Guo GL; Braddock M; Zheng MH
Oncotarget; 2015 Aug; 6(23):19880-90. PubMed ID: 26082438
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and colorectal cancer: a cross-sectional survey.
Forootan M; Tabatabaeefar M; Yahyaei M; Maghsoodi N
Asian Pac J Cancer Prev; 2012; 13(10):4999-5002. PubMed ID: 23244098
[TBL] [Abstract][Full Text] [Related]
8. Nicotine downregulates microRNA-200c to promote metastasis and the epithelial-mesenchymal transition in human colorectal cancer cells.
Lei Z; Xiaomin Y; He H; Jian C; Xiaowu X
J Cell Physiol; 2019 Feb; 234(2):1369-1379. PubMed ID: 30076725
[TBL] [Abstract][Full Text] [Related]
9. Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults.
Garg T; Young AJ; O'Keeffe-Rosetti M; McMullen CK; Nielsen ME; Murphy TE; Kirchner HL
Urol Oncol; 2020 Sep; 38(9):737.e17-737.e23. PubMed ID: 32409197
[TBL] [Abstract][Full Text] [Related]
10. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer and its association with the metabolic syndrome: a Malaysian multi-centric case-control study.
Ulaganathan V; Kandiah M; Zalilah MS; Faizal JA; Fijeraid H; Normayah K; Gooi BH; Othman R
Asian Pac J Cancer Prev; 2012; 13(8):3873-7. PubMed ID: 23098486
[TBL] [Abstract][Full Text] [Related]
12. Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China.
Wang Z; Chen R; Zhang L; Chen Y; Li J; Li S; Xu L; Hu Y; Bai Y
Eur J Cancer Prev; 2024 Jul; 33(4):347-354. PubMed ID: 38375832
[TBL] [Abstract][Full Text] [Related]
13. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
14. Impact of metabolic syndrome on the prognosis of ischemic stroke secondary to symptomatic intracranial atherosclerosis in Chinese patients.
Mi D; Zhang L; Wang C; Liu L; Pu Y; Zhao X; Wang Y; Wang Y
PLoS One; 2012; 7(12):e51421. PubMed ID: 23251528
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a post-operative surveillance strategy for stage I colorectal cancer patients based on a novel recurrence risk stratification: a multicenter retrospective study.
Ozawa T; Hashiguchi Y; Ishihara S; Hayama T; Tsuchiya T; Nozawa K; Yamauchi S; Sugihara K; Matsuda K
Int J Colorectal Dis; 2021 Jan; 36(1):67-74. PubMed ID: 32865715
[TBL] [Abstract][Full Text] [Related]
16. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study.
Chung KC; Juang SE; Chen HH; Cheng KC; Wu KL; Song LC; Lee KC
BMC Gastroenterol; 2022 Nov; 22(1):453. PubMed ID: 36368935
[TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
18. Effect of abdominal aortic calcification on the prognosis and recurrence of colorectal cancer stages II-III: A retrospective cohort study.
Imaoka K; Shimomura M; Shimizu W; Akabane S; Ohira M; Imaoka Y; Yoshinaka H; Ono K; Mochizuki T; Matsubara K; Bekki T; Hattori M; Ohdan H
Int J Colorectal Dis; 2023 Jan; 38(1):21. PubMed ID: 36680603
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is associated with increased risk of recurrent colorectal adenomas in Korean men.
Kim MC; Jung SW; Kim CS; Chung TH; Yoo CI; Park NH
Int J Obes (Lond); 2012 Jul; 36(7):1007-11. PubMed ID: 21894158
[TBL] [Abstract][Full Text] [Related]
20. Advanced Age Is a Risk Factor for Recurrence After Resection in Stage II Colorectal Cancer.
Mima K; Kurashige J; Miyanari N; Morito A; Yumoto S; Matsumoto T; Kosumi K; Inoue M; Mizumoto T; Kubota T; Baba H
In Vivo; 2020; 34(1):339-346. PubMed ID: 31882497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
